title: Risk assessment in haematopoietic stem cell transplantation: histocompatibility.
abstract: Consideration of potential donors for transplantation includes a rigorous assessment of the availability and HLA-match status of family members, and the identification of suitable unrelated donors when related donors are not available. Because HLA gene products provoke host-versus-graft and graft-versus-host alloimmune responses, HLA matching serves a critical preventive role in lowering risks of graft failure and graft-versus-host disease (GVHD). At the same time, graft-versus-leukemia effects associated with HLA mismatching may provide an immunological means to lower the recurrence of post-transplant disease in high-risk patients. The definition of a suitable allogeneic donor is ever changing, shaped not only by current typing technology for the known HLA genes but also by the specific transplant procedure. Increased safety of alternative donor hematopoietic cell transplantation (HCT) has been achieved in part through advances in the field of immunogenetics. Increased availability of HCT through the use of HLA-mismatched related and unrelated donors is feasible with a more complete understanding of permissible HLA mismatches and the role of NK-KIR genes in transplantation.
authors: Department of Medicine, University of Washington, 1959 Northeast Pacific, Seattle, WA 98195, USA. epetersd@fhcrc.org
authors: Effie W
authors: EW
authors: Petersdorf
mesh_terms: D005190:Family; D005787:Gene Frequency; D006086:Graft vs Host Disease / Q000517:prevention & control; D020544:Graft vs Leukemia Effect / Q000276:immunology; D006680:HLA Antigens / Q000235:genetics; D006239:Haplotypes / Q000235:genetics; D018380:Hematopoietic Stem Cell Transplantation; D006648:Histocompatibility / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D011971:Receptors, Immunologic / Q000235:genetics; D054340:Receptors, KIR; D018570:Risk Assessment; D014019:Tissue Donors; D014184:Transplantation, Homologous
chemical_list: D006680:HLA Antigens; D011971:Receptors, Immunologic; D054340:Receptors, KIR